Loading viewer...
investor_presentation
Format: PDF investor_presentation
Investor presentation for Onvansertib, a precision medicine therapeutic candidate, highlighting the company's management team and clinical development strategy. The deck outlines the company's approach to turning the tide on cancer through novel drug development and biomarker technology expertise.
investor_presentation
25 Pages
Asian Paints
Telstra Investor Update European Roadshow 2016
investor_presentationinvestor_presentation
44 Pages
Telstra Corporation Limited